Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial

被引:7
|
作者
Kitazawa, Masaru [1 ]
Takeda, Yasunaga [1 ]
Hatta, Mariko [1 ]
Horikawa, Chika [2 ]
Sato, Takaaki [1 ]
Osawa, Taeko [1 ]
Ishizawa, Masahiro [1 ]
Suzuki, Hiroshi [1 ]
Matsubayashi, Yasuhiro [1 ]
Fujihara, Kazuya [1 ]
Yamada, Takaho [1 ]
Sone, Hirohito [1 ,3 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata 9518510, Japan
[2] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata 9500806, Japan
[3] Niigata Univ, Dept Internal Med, Fac Med, 1-754 Asahimachi, Niigata 9518510, Japan
关键词
continuous blood glucose monitor; prevention; prospective randomized trial; smartphone; educational intervention; DOSE-RESPONSE METAANALYSIS; HEALTH MANAGEMENT CENTER; PHYSICAL-ACTIVITY; GLUCOSE-LEVELS; JAPANESE; INDIVIDUALS; PREVENTION; HBA1C;
D O I
10.1210/clinem/dgad639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle intervention program combining lifestyle coaching via a smartphone application augmented by intermittently scanned continuous glucose monitoring without burdening health care providers. Its effectiveness for glycemic control and body weight reduction in people at risk of type 2 diabetes was investigated.Materials and Methods: For this 12-week randomized unblinded trial with offline recruitment, participants with a hemoglobin A1c level of 5.6% to 6.4% or a fasting blood glucose of 110 to 125 mg/dL and body mass index (BMI) >23 kg/m2 but <40 kg/m(2) were randomly assigned to the intervention group (App) and control group (C). The primary endpoint was the difference in time in range of blood glucose between 70 and 140 mg/dL (3.9-7.8 mmol/L) before and after the study period between the 2 groups.Results: Among 168 patients (mean age, 48.1 years; mean BMI, 26.6 kg/m(2); and male, 80.4%), 82 and 86 were assigned to the App group and C group, respectively. After 12 weeks, time in range of blood glucose at 70 to 140 mg/dL significantly improved in the App group compared with the C group (-2.6 minutes/day vs +31.5 minutes/day, P = .03). Changes in time above range did not differ, whereas time below range (blood glucose <70 mg/dL; +23.5 minutes/day vs -8.9 minutes/day, P = .02) improved in the App group. BMI (-0.26 vs -0.59, P = .017) was reduced in the App group compared with the C group.Conclusion: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring increased glycemic control accompanied by decreased carbohydrate intake and weight loss. Further trials are needed to confirm whether these interventions can reduce incident type 2 diabetes.
引用
收藏
页码:1060 / 1070
页数:11
相关论文
共 50 条
  • [21] The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial
    Hummel, Madeleine
    Bonn, Stephanie Erika
    Lagerros, Ylva Trolle
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
  • [22] Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial
    Kaewdech, Apichat
    Assawasuwannakit, Suraphon
    Churuangsuk, Chaitong
    Chamroonkul, Naichaya
    Sripongpun, Pimsiri
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] Well-Being Therapy and lifestyle Intervention in Type 2 Diabetes: A Pilot Randomized Controlled Trial
    Benasi, Giada
    Gostoli, Sara
    Zhu, Boheng
    Offidani, Emanuela
    Artin, Michael G.
    Gagliardi, Lorenza
    Rignanese, Giovanni
    Sassi, Graziella
    Fava, Giovanni A.
    Rafanelli, Chiara
    PSYCHOSOMATIC MEDICINE, 2022, 84 (09): : 1041 - 1049
  • [24] Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
    Johansen, Mette Yun
    MacDonald, Christopher Scott
    Hansen, Katrine Bagge
    Karstoft, Kristian
    Christensen, Robin
    Pedersen, Maria
    Hansen, Louise Seier
    Zacho, Morten
    Wedell-Neergaard, Anne-Sophie
    Nielsen, Signe Tellerup
    Iepsen, Ulrik Wining
    Langberg, Henning
    Vaag, Allan Arthur
    Pedersen, Bente Klarlund
    Ried-Larsen, Mathias
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 637 - 646
  • [25] Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia A Randomized Clinical Trial
    Sampson, Michael
    Clark, Allan
    Bachmann, Max
    Garner, Nikki
    Irvine, Lisa
    Howe, Amanda
    Greaves, Colin
    Auckland, Sara
    Smith, Jane
    Turner, Jeremy
    Rea, Dave
    Rayman, Gerry
    Dhatariya, Ketan
    John, W. Garry
    Barton, Garry
    Usher, Rebecca
    Ferns, Clare
    Pascale, Melanie
    JAMA INTERNAL MEDICINE, 2021, 181 (02) : 168 - 178
  • [26] Using a smartphone app in changing cardiovascular risk factors: A randomized controlled trial (EVIDENT II study)
    Gonzalez-Sanchez, Jesus
    Recio-Rodriguez, Jose, I
    Fernandez-delRio, Alicia
    Sanchez-Perez, Alvaro
    Felix Magdalena-Belio, Jose
    Gomez-Marcos, Manuel A.
    Garcia-Ortiz, Luis
    Gomez-Marcos, Manuel A.
    Rodriguez-Sanchez, Emiliano
    Maderuelo-Fernandez, Jose A.
    Iglesias-Valiente, Jose A.
    Patino-Alonso, Maria C.
    Perez-Arechaederra, Diana
    Mora-Simon, Sara
    Agudo-Conde, Cristina
    Castano-Sanchez, Maria C.
    Rodriguez-Martin, Carmela
    Sanchez-Salgado, Benigna
    de Cabo-Laso, Angela
    Alonso-Dominguez, Rosario
    Sanchez-Aguadero, Natalia
    Martin-Cantera, Carlos
    Canales-Reina, Jose
    Rodrigo de Pablo, Epifania
    Lasaosa-Medina, Maria L.
    Calvo-Aponte, Maria J.
    Rodriguez-Franco, A.
    Martin-Borras, Carmen
    Puig-Ribera, Anna
    Colominas-Garrido, Ruben
    Puigdomenech Puig, Elisa
    Romaguera-Bosch, Monserrat
    Maneus, Sandra
    Schmolling-Guinovart, Yolanda
    Rodriguez-Martin, Beatriz
    Fernandez del Rio, Alicia
    Fernandez-Diaz, Jose A.
    Calderon-Ubeda, Jose B.
    Menendez-Obregon, Jose L.
    Segura-Fragoso, Antonio
    Zabala-Banos, Carmen
    Martinez-Vizcaino, Vicente
    Martinez-Andres, Maria
    Fernandez-Alonso, Maria C.
    Gomez-Arranz, Amparo
    de la Cal de la Fuente, Aventina
    Menendez-Suarez, Marta
    Repiso-Gento, Irene
    Arranz-Hernando, Maria, I
    Perez-Concejo, Maria, I
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2019, 125 : 13 - 21
  • [27] Lifestyle Advice Combined with Personalized Estimates of Genetic or Phenotypic Risk of Type 2 Diabetes, and Objectively Measured Physical Activity: A Randomized Controlled Trial
    Godino, Job G.
    van Sluijs, Esther M. F.
    Marteau, Theresa M.
    Sutton, Stephen
    Sharp, Stephen J.
    Griffin, Simon J.
    PLOS MEDICINE, 2016, 13 (11):
  • [28] A Smartphone App to Restore Optimal Weight (SPAROW) in Women With Recent Gestational Diabetes Mellitus: Randomized Controlled Trial
    Lim, Karen
    Chan, Shiao-Yng
    Lim, Su Lin
    Tai, Bee Choo
    Tsai, Cammy
    Wong, Su Ren
    Ang, Siew Min
    Yew, Tong Wei
    Tai, E. Shyong
    Yong, Eu Leong
    JMIR MHEALTH AND UHEALTH, 2021, 9 (03):
  • [29] Changes in dietary intake following a culturally adapted lifestyle intervention among Iraqi immigrants to Sweden at high risk of type 2 diabetes: a randomised trial
    Siddiqui, Faiza
    Winther, Vicky
    Kurbasic, Azra
    Sonestedt, Emily
    Lundgren, Katarina Balcker
    Lindeberg, Staffan
    Nilsson, Peter M.
    Bennet, Louise
    PUBLIC HEALTH NUTRITION, 2017, 20 (15) : 2827 - 2838
  • [30] A Pregnancy and Postpartum Lifestyle Intervention in Women With Gestational Diabetes Mellitus Reduces Diabetes Risk Factors A feasibility randomized control trial
    Ferrara, Assiamira
    Hedderson, Monique M.
    Albright, Cheryl L.
    Ehrlich, Samantha F.
    Quesenberry, Charles P., Jr.
    Peng, Tiffany
    Feng, Juanran
    Ching, Jenny
    Crites, Yvonne
    DIABETES CARE, 2011, 34 (07) : 1519 - 1525